Clinical Trials Logo

Remote Ischemic Preconditioning clinical trials

View clinical trials related to Remote Ischemic Preconditioning.

Filter by:

NCT ID: NCT05990907 Active, not recruiting - Hemodynamics Clinical Trials

Influence of RIC on the Orthostatic Competence of the Microcirculation

Start date: July 30, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial (pilot study) is to learn about the microcirculatory regulation of the lower extremity under orthostatic stress with and without RIC - Remote Ischemic Preconditioning in healthy participants. The main question it aims to answer are: Do the beneficial effects of RIC withstand orthostatic stress? / Does RIC benefit lower extremity microcirculation in ortho-statically stressed subjects? Is there a relationship/correlation between the variables of microcirculation and hemodynamics in the context of RIC and orthostatic loading?

NCT ID: NCT05733208 Recruiting - Myocardial Injury Clinical Trials

The Effect of Remote Ischemic Preconditioning on Myocardial Injury After Noncardiac Surgery

Start date: May 6, 2023
Phase: N/A
Study type: Interventional

This is a multicentre, parallel-group, randomised, sham-controlled, observer blinded trial, assessing the efficacy of remote ischemic preconditioning on preventing myocardial injury after noncardiac surgery.

NCT ID: NCT04064658 Suspended - Moyamoya Disease Clinical Trials

Effects of Remote Ischemic Pre-Conditioning in Moyamoya Disease Patients

RIME
Start date: October 1, 2019
Phase: N/A
Study type: Interventional

In the present study, investigators evaluated whether RIPC reduce the major neurological complications in adult moyamoya disease patients undergoing encephaloduroarteriosynangiosis (EDAS).

NCT ID: NCT03761368 Completed - Clinical trials for Remote Ischemic Preconditioning

Remote Ischemic Preconditioning and Contrast Induced - Acute Kidney Injury in Patients Undergoing Elective PCI

Start date: March 1, 2015
Phase: N/A
Study type: Interventional

Prospective, randomized, sham-controlled clinical study was conducted to assess whether RIPC reduces the incidence of CI-AKI measured standard way of using SCr concentration but also with the use of serum NGAL as a new potential biomarker of kidney injury. Furthermore, the aim of investigation was to analyse the safety and clinical outcomes of RIPC after elective coronary angiography (CA) followed by percutaneous coronary intervention (PCI).

NCT ID: NCT03474952 Completed - Clinical trials for Remote Ischemic Preconditioning

Effects of Remote Ischemic Preconditioning During Free Flap Reconstruction

Start date: April 13, 2018
Phase: N/A
Study type: Interventional

Remote ischemic preconditioning (RIPC) has been revealed organ-protective effect in many previous clinical settings including coronary intervention or cardiovascular surgery. However its protective role during free flap reconstructive surgery in head and neck cancer patients has not yet been elucidated. The purpose of the current study is to evaluate the effect of RIPC on tissue oxygen saturation and skin temperature of the flap, as well as its organ-protective effect using Langendorff isolated heart ischemia-reperfusion model.

NCT ID: NCT03072914 Completed - Moyamoya Disease Clinical Trials

Effects of Remote Ischemic Preconditioning With Postconditioning on Neurologic Outcome

Start date: March 7, 2017
Phase: N/A
Study type: Interventional

In the present study, we evaluated whether RIPC with RIPostC reduce the major neurocomplication in patients undergoing STA-MCA anastomosis.

NCT ID: NCT03027011 Recruiting - Brain Injuries Clinical Trials

Remote Ischemic Preconditioning on Brain Injury in Carotid Endarterectomy

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

This is a randomized controlled trial designed to test an intervention (Remote ischemic preconditioning) in patients undergoing carotid endarterectomy (CEA).Remote ischemic preconditioning(RIPC) with transient upper limb ischemia/reperfusion is a novel, simple, cost-free,non-pharmacological and non-invasive strategy.The purpose of this study is to evaluate the effects of Remote Ischaemic Preconditioning on perioperative ischaemic injury in patients undergoing carotid endarterectomy compared to control intervention.The outcomes of interest include neurocognitive function,clinical outcomes,and biomarkers of brain injury.

NCT ID: NCT03016182 Recruiting - Lung Injury Clinical Trials

Remote Ischemic Preconditioning on Pulmonary Injury in Cardic Surgery

Start date: February 7, 2017
Phase: N/A
Study type: Interventional

During cardiac surgery with cardiopulmonary bypass , pulmonary dysfunction remains to be a problem complicating the postoperative course of the patients.Remote ischemic preconditioning(RIPC) with transient upper limb ischemia/reperfusion is a novel, simple, cost-free,non-pharmacological and non-invasive strategy.Recent several trials suggested that RIPC could provide pulmonary protection by reducing serum biomarkers,however,whether the RIPC can improve the clinical outcomes in patients undergoing on-pump cardiac surgery,is still uncertain. The study hypothesis is: remote ischemic preconditioning will provide lung-protective effect and improve clinical outcomes in patients undergoing cardic surgery.

NCT ID: NCT03010839 Completed - Myocardial Injury Clinical Trials

Cardiopulmonary Protective Effects of Modified Remote Ischaemic Preconditioning in Mitral Valve Replacement Surgery

Start date: November 5, 2016
Phase: N/A
Study type: Interventional

During cardiac surgery with cardiopulmonary bypass , injury occurs to the heart muscle and the lung.The heart and lung injury is a serious complication ,which increases both mortality and morbidity of cardiac surgery .Remote ischemic preconditioning(RIPC) with transient upper limb ischemia/reperfusion is a novel, simple, cost-free,non-pharmacological and non-invasive strategy.Recent some trials suggested that RIPC could provide myocardial protection by reducing serum cardiac biomarkers,however, more recent multicenter studies[9-11] had failed to show the protective effects of RIPC with respect to the troponin release and lung injury. Remote ischemic preconditioning (RIPC) is reported to have the early-phase and delayed-phase organ protective effects, whether the modified RIPC protocol induced repeatedly has the cardiopulmonary protective effect is still uncertain.

NCT ID: NCT00546390 Completed - Clinical trials for Remote Ischemic Preconditioning

Protection of the Heart With Remote Ischemic Preconditioning During Heart Surgery: A Pilot Study

Start date: November 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to compare a treatment called remote ischemic preconditioning (rIP) to no treatment. rIP is a simple treatment that is believed to help patients recover better after heart surgery. This treatment involves applying a large blood pressure cuff to one leg. The blood pressure cuffs will be inflated for 5 minutes and then deflated for 5 minutes. This will be done 4 times in a row.